Identifies themes and clusters of stock movements
Market TodayThemes and Stocks AnalysesThematic Stock SearchClick here for daily refresh schedule
Coronavirus Vaccine Stocks$448.09
0.38%4:00PM 11/23/2020
Investors are bidding up companies trying to alleviate the coronavirus outbreak, from biotechs working on treatments and vaccines to telemedicine companies catering for the sick stuck at home.
Latest intraday update before market close @ 19:45:00 PM 11/23/2020
Summary :
Average return is up 0.5%
Median return is down -0.1%
5 out of 10 stocks are up (limited to those with intraday pricing feeds).

Aggregated price index

Aggregated price index with volume information


  • Coronavirus Vaccine stocks up 0.4% on average while median return up 0.0% in a day
  • Coronavirus Vaccine stocks down 0.4% on average while median return down -1.1% in a week
  • Coronavirus Vaccine stocks up 5.8% on average while median return up 1.1% in a month
  • When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.

Aggregated price index is based on equal weighted constituencies returns,Aggregated volume information is based on sum of all constituencies volumes

Index Constituencies

Related ETFs (click on ticker for detail)

leak data

  • 1M winners are : Winners for past month are $MRNA 42.6%, $VXRT 30.6%, $BNTX 23.6%, $ABBV 21.2%, $BCRX 14.3%
  • 1M losers are : Losers for past month are $NNVC -3.4%, $INO -7.7%, $AEMD -8.9%, $EBS -18.4%, $IBIO -25.8%
  • 1W winners are : Winners for past week are $VXRT 27.7%, $BNTX 16.6%, $NNVC 5.6%, $ABBV 3.9%, $NVAX 3.6%
  • 1W losers are : Losers for past week are $JNJ -4.5%, $DVAX -4.8%, $EBS -8.1%, $INO -19.3%, $IBIO -28.3%
Pick two stocks to compare:

Correlation Analysis

Index correlation analysis

Correlation for the past month is 20.2%, for the past 3 months is 23.0%

In the past month for a 5 days rolling window, the highest corrrelation is 49.8%, the lowest correlation is 0.5%, the latest correlation is 20.1%

When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.

Among pairwise correlation, the highest correlation is 73.6% between ICCC and SNY

The lowest correlation is -56.2% between PFE and VXRT

Stock news

    FDA panel to discuss emergency use of Pfizer COVID-19 vaccine on Dec. 10

    The U.S. Food and Drug Administration's outside advisers will meet on Dec. 10 to discuss whether to authorize the COVID-19 vaccine developed by Pfizer Inc and German partner BioNTech for emergency use, the agency said on Friday. The move comes after Pfizer applied for the authorization of its COVID-19 vaccine earlier in the day, the first such application in a major step toward providing protection against the new coronavirus. "While we cannot predict how long the FDA's review will take, the F...

    Stock Market Holds Near Highs Amid Coronavirus News, Target, Nio Earnings Top, Tesla To Join S&P 500

    The stock market held near highs amid coronavirus news from new restrictions to Covid vaccines. Target and Nio earnings beat. Tesla will join the S&P 500.

    BioNTech, Pfizer Ready To Submit Coronavirus Vaccine To FDA

    Shares of BioNTech and Pfizer rose after the pharmaceutical companies announced they would submit their coronavirus vaccine to U.S. regulators Friday, the first drugmakers to seek approval.

    Biggest risk to markets is volatility: Expert

    Keith Fitz-Gerald, Fitz-Gerald Group Chief Investment Officer, joins Yahoo Finance's Kristin Myers to discuss the latest market action, as coronavirus cases continue to spike.

    Trump administration will 'likely bungle' COVID-19 vaccine distribution: Doctor

    Dr. Rishi Desai, Chief Medical Officer at Osmosis & Former Center for Disease Control and Prevention Epidemic Intelligence Officer joins Yahoo Finance's Kristin Myers to break down the latest coronavirus developments as Pfizer and BioNTech submit their vaccine for emergency authorization.

    Dow Jones Slips As Covid Continues To Surge; Nio Charges Higher As Tesla Sputters

    The Dow Jones lost ground as global coronavirus cases continue to rise. Chinese electric-car stock Nio charged higher, while Tesla is near buy zone.

    Remdesivir’s Failure Is a Warning for Covid-19 Vaccines

    (Bloomberg Opinion) -- Less than a month ago, the Food and Drug Administration said hospitals could use remdesivir, a drug manufactured by Gilead Sciences Inc., to treat patients with Covid-19. Remdesivir, sold under the brand name Veklury, was said to shorten recovery times and reduce the need for ventilators to facilitate breathing. Yesterday, the World Health Organization hit the brakes: It recommended that doctors avoid using the drug altogether.“There is currently no evidence that remdesivi...

    U.S. moves closer to 200,000 daily COVID cases; Birx and Fauci urge Americans to follow safety measures over Thanksgiving

    The global case tally for the coronavirus illness COVID-19 climbed above 57 million on Friday, and the U.S. moved closer to 200,000 cases in a day and set a fresh record for hospitalizations as the virus continues to infect people in every state and region.

    US STOCKS-S&P 500, Dow dip on concerns over rising COVID-19 infections

    The S&P 500 and the Dow slipped on Friday with a surge in coronavirus cases threatening to derail a fragile economic recovery, even as plans were announced for ending several of the Federal Reserve's economic support programs. The Nasdaq edged 0.2% higher, boosted by a rise in shares of stay-at-home darlings Zoom Video Communications Inc and Inc.

    UK asks regulator to assess Pfizer vaccine for suitability

    Britain has formally asked its medical regulator, the MHRA, to assess the vaccine being produced by Pfizer Inc and its German partner BioNTech , health minister Matt Hancock said on Friday. Pfizer said it would apply to U.S. health regulators on Friday for emergency use authorization (EUA) of its COVID-19 vaccine, the first such application in a major step toward providing protection against the new coronavirus. "Here in the UK, the first step for authorising a vaccine is for the government fo...